si-hVDAC1 tumour treatment also decreased the expression of the cell proliferation marker Ki-67, as shown by IHC staining and quantitative analysis (70–80%) or by q-RT-PCR analysis (2.8 to 3.1-fold) (Figure 2G–I). This evidence concerns the gene MKI67 and neoplasm.